Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961778 · ClinicalTrials.gov registry record · NA
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01961778 is a NA study of Barrett's Esophagus that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01961778, a NA study of Barrett's Esophagus, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective randomized study comparing radiofrequency ablation and cryotherapy for the endoscopic treatment of Barrett's esophagus. The study is powered to assess clinical equivalence (non-inferior) of the treatment regimens.
Conditions Studied
Interventions
- DEVICE Cryotherapy
- DEVICE Radio-Frequency Ablation
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-11 |
| Est. Completion | 2020-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01961778
The ClinicalTrials.gov registry entry for NCT01961778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 522-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (90% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 2 interventions - of which Cryotherapy is the first listed.
NCT01961778 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01961778 about?
NCT01961778 is a clinical study titled "Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma". Prospective randomized study comparing radiofrequency ablation and cryotherapy for the endoscopic treatment of Barrett's esophagus. The study is powered to assess clinical equivalence (non-inferior) of the treatment regimens.
What is the current status of trial NCT01961778?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-11. Estimated completion is 2020-02-01.
What conditions does trial NCT01961778 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT01961778?
The interventions under investigation include: Cryotherapy (DEVICE), Radio-Frequency Ablation (DEVICE).
Who is sponsoring clinical trial NCT01961778?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961778 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
-
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
ACTIVE NOT RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.